1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early experience using radiotherapy as a salvage treatment for relapsed or refractory non-Hodgkin lymphomas following CD19 chimeric antigen receptor modified T-cell therapy
    Meeting Abstract

    Imber, B.; Palomba, M. L.; DeSelm, C.; Dahi, P. B.; Sauter, C. S.; Scordo, M.; Batlevi, C. L.; Park, J. H.; Shah, G. L.; Giralt, S. A.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • MSKCC early experience using radiotherapy as a bridging strategy for relapsed diffuse large B cell lymphoma before CD19 CAR T therapy
    Meeting Abstract

    Imber, B.; Palomba, M. L.; DeSelm, C.; Batlevi, C. L.; Dahi, P. B.; Giralt, S. A.; Noy, A.; Park, J. H.; Sauter, C. S.; Scordo, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Phase Ib of copanlisib in combination with ibrutinib in recurrent/refractory primary CNS lymphoma (PCNSL)
    Meeting Abstract

    Grommes, C.; Gavrilovic, I.; Miller, A. M.; Stone, J. B.; Kaley, T.; Madzsar, J. T.; Schumpp, A.; Butler, B. T.; Schaff, L.; Mellinghoff, I. K.
    Blood (2019)

    Fulltext@MSK | Save
  • Aberrant responsiveness of erythropoiesis to iron deficiency in polycythemia vera
    Meeting Abstract

    Feola, M.; Moskop, D.; Terra, N.; Park, Y. C.; Dunbar, A.; Levine, R. L.; Hoffman, R.; Ginzburg, Y.
    Blood (2019)

    Fulltext@MSK | Save
  • Use of machine learning in 2074 cases of acute myeloid leukemia for genetic risk profiling
    Meeting Abstract

    Fleming, S.; Tsai, C. H.; Döhner, H.; Döhner, K.; Papaemmanuil, E.; Tien, H. F.; Reynolds, J.; Wei, A. H.; Hou, H. A.
    Blood (2019)

    Fulltext@MSK | Save
  • Landscape of TP53 mutations in MPN
    Meeting Abstract

    Farnoud, N.; Famulare, C.; Papaemmanuil, E.; McGovern, E.; Medina, J.; Arango Ossa, J. E.; Rampal, R. K.; Li, B.; Levine, R. L.; Mascarenhas, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Comparative somatic mutational profiling of CD34+ hematopoietic precursors (HSC) and circulating endothelial cells (CEC) in patients with primary myelofibrosis (PMF)
    Meeting Abstract

    Farina, M.; Bernardi, S.; Polverelli, N.; Zanaglio, C.; Malagola, M.; Re, F.; Cattina, F.; D'Adda, M.; Rossi, G.; Zollner, T.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Allogeneic CD34-selected HSCT following CAR T-cells is associated with low TRM and favorable OS in pediatric/young adult patients with relapsed/refractory B-ALL
    Meeting Abstract

    Fabrizio, V.; Boulad, F.; Cancio, M. I.; Higman, M. A.; Margossian, S. P.; Mauguen, A.; Prockop, S.; Scaradavou, A.; Shah, N. C.; Spitzer, B.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • De novo myelodysplastic syndromes in patients 20-50 years old characterized by frequent mutations in TP53 and transcription-related genes
    Meeting Abstract

    Epstein-Peterson, Z. D.; Spitzer, B.; McCarter, J.; McGovern, E.; Levine, R. L.; Tallman, M. S.
    Blood (2019)

    Fulltext@MSK | Save
  • Identifying cytokine biomarkers of response to pegylated-interferon therapy in polycythemia vera and essential thrombocythemia: Correlative analysis from the MPN-RC 111/112 trials
    Meeting Abstract

    Dunbar, A.; Kosiorek, H. E.; Krishnan, A.; McGovern, E.; Park, Y.; Patel, M. A.; Singer Weinberg, R.; Yacoub, A.; Dueck, A. C.; Mascarenhas, J.; more...
    Blood (2019)

    Fulltext@MSK | Save